<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An adjuvant therapy to prolong the therapeutic window for <z:hpo ids='HP_0001297'>stroke</z:hpo> patients is urgently needed </plain></SENT>
<SENT sid="1" pm="."><plain>This randomized, blinded, placebo-controlled study investigated adjuvant intravenous <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="95" ids="16301">nitrite</z:chebi> with recombinant tissue plasminogen activator (rtPA) in middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) with 6 and 2 h of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> followed by reperfusion in Sprague-Dawley rats (n=59) </plain></SENT>
<SENT sid="2" pm="."><plain>Quantitative diffusion, T(1)-, T(2)-weighted, and semiquantitative perfusion imaging were performed before and after reperfusion and at 48 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> to determine the spatiotemporal evolution of <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>After 48 h animals were killed and examined to evaluate <z:mpath ids='MPATH_124'>infarct</z:mpath> size and evidence of hemorrhagic transformation </plain></SENT>
<SENT sid="4" pm="."><plain>Factor VIII immunostaining was performed to assess vessel <z:mp ids='MP_0000002'>morphology</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="95" ids="16301">Nitrite</z:chebi> treatment (6 h group: 37.5 micromol for more than 90 mins; 2 h group: 26.25 and 1.75 micromol for more than 60 mins) did not reduce <z:mpath ids='MPATH_124'>infarct</z:mpath> volume 48 h after MCAO compared with saline-treated placebo groups after 6 or 2 h of MCAO </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> progression from baseline to 48 h, based on the apparent diffusion coefficient and relative cerebral blood flow deficits before and after reperfusion and T(2)-weighted hyperintensity at 48 h, did not differ between treated and control animals </plain></SENT>
<SENT sid="7" pm="."><plain>These results suggest that <z:chebi fb="95" ids="16301">nitrite</z:chebi> is not a protective adjuvant therapy to delayed rtPA administration after <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> in rats </plain></SENT>
</text></document>